Contract Award

Physiomics plc (AIM: PYC), a leading mathematical modelling company, supporting development of oncology drugs and personalised medicine solutions, is pleased to announce that it has been awarded its first contract with a new UK-based biotech client.  The contract, which has a value of £125,000 and relates to a project in the immune-oncology field, is expected to be completed within this calendar year.

Physiomics CEO, Dr Jim Millen, commented:

“We are delighted to have been chosen by this new client to support the development of its lead asset.  We look forward to working with them on this exciting project.”